organic compounds\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 65| Part 5| May 2009| Pages o1015-o1016

1-[4-(Di­fluoro­meth­oxy)phenyl]-N-(2,3-di­methylphenyl)-1H-1,2,4-triazole-3-carboxamide

aCollege of Biological and Environmental Engineering, Zhejiang University of Technology, Hangzhou 310014, People's Republic of China, bSchool of Pharmaceutial and Chemical Engineering, Taizhou University, Taizhou 317000, People's Republic of China, cZhejiang University of Technology, Hangzhou 310014, People's Republic of China, and dZhejiang Research Institute of Chemical Industry, Hangzhou 310023, People's Republic of China
*Correspondence e-mail: yuguangw@zjut.edu.cn

(Received 23 January 2009; accepted 3 April 2009; online 10 April 2009)

In the mol­ecule of the title compound, C18H16F2N4O2, the 1,2,4-triazole ring forms dihedral angles of 3.6 (2) and 14.9 (6)° with the 4-difluoro­meth­oxy-substituted benzene ring and the 2,3-dimethyl-substituted benzene ring, respectively. The OCHF2 group is twisted away from the plane of the benzene ring, as shown by the C—O—C—C torsion angle of 145.8 (2)°. The conformation is stabilized by an inter­molecular N—H⋯N hydrogen bond. In the crystal, short C—H⋯O inter­actions lead to chains of mol­ecules.

Related literature

For general background regarding the biological and pharmacological activities of 1,2,4-triazoles and their derivatives, see: Wahbi et al. (1995[Wahbi, Y., Caujolle, R., Tournaire, C., Payard, M., Linas, M. D. & Seguela, J. P. (1995). Eur. J. Med. Chem. 30, 955-962.]); Chai et al. (2003[Chai, B., Qian, X., Cao, S., Liu, H. & Song, G. (2003). Arkivoc. ii, 141-145.]); Hashimoto et al. (1990[Hashimoto, F., Sugimoto, C. & Hayashi, H. (1990). Chem. Pharm. Bull. 38, 2532-2536.]); Kalluraya et al. (1996[Kalluraya, B., Shetty, S. N., Gunaga, P. & Holla, B. S. (1996). Boll. Chim. Farm. 135, 638-642.]); Almasirad et al. (2004[Almasirad, A., Tabatabai, S. A., Faizi, M., Kebriaeezadeh, A., Mehrabi, N., Dalvandi, A. & Shafiee, A. (2004). Bioorg. Med. Chem. Lett. 14, 6057-6059.]); Amir & Shikha (2004[Amir, M. & Shikha, K. (2004). Eur. J. Med. Chem. 39, 535-545.]); Kanazawa et al. (1988[Kanazawa, S., Driscoll, M. & Struhl, K. (1988). Mol. Cell. Biol. 8, 644-673.]); Vlasova et al. (1971[Vlasova, L. A., Shamaeva, E. M., Afanaséva, G. B. & Postvskii, I. Y. (1971). Pharm. Chem. J. 5, 473-477.]); Labanauskas et al. (2004[Labanauskas, L., Udrenaite, E., Gaidelis, P. & Brukštus, A. (2004). Farmaco, 59, 255-259.]); Tozkoparan et al. (2007[Tozkoparan, B., Küpeli, E., Yeşilada, E. & Ertan, M. (2007). Bioorg. Med. Chem. 15, 1808-1814.]). For a related synthesis, see: Drutkowski et al. (2002[Drutkowski, G., Donner, Ch., Schulze, I. & Frohberg, P. (2002). Tetrahedron, 58, 5317-5326.]); Frohberg et al. (2002[Frohberg, P., Drutkowski, G. & Wagner, Ch. (2002). Eur. J. Org. Chem. pp. 1654-1663.]).

[Scheme 1]

Experimental

Crystal data
  • C18H16F2N4O2

  • Mr = 358.35

  • Triclinic, [P \overline 1]

  • a = 7.5543 (10) Å

  • b = 7.8132 (10) Å

  • c = 14.8190 (19) Å

  • α = 95.974 (2)°

  • β = 98.593 (1)°

  • γ = 101.523 (1)°

  • V = 839.28 (19) Å3

  • Z = 2

  • Mo Kα radiation

  • μ = 0.11 mm−1

  • T = 296 K

  • 0.49 × 0.31 × 0.10 mm

Data collection
  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2004[Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.948, Tmax = 0.990

  • 6446 measured reflections

  • 3115 independent reflections

  • 2366 reflections with I > 2σ(I)

  • Rint = 0.017

Refinement
  • R[F2 > 2σ(F2)] = 0.042

  • wR(F2) = 0.123

  • S = 1.06

  • 3115 reflections

  • 238 parameters

  • H-atom parameters constrained

  • Δρmax = 0.23 e Å−3

  • Δρmin = −0.21 e Å−3

Table 1
Hydrogen-bond geometry (Å, °)

D—H⋯A D—H H⋯A DA D—H⋯A
N4—H4D⋯N3 0.86 2.27 2.717 (2) 113
C6—H6⋯O2i 0.93 2.43 3.344 (2) 169
C8—H8⋯O2i 0.93 2.26 3.159 (2) 162
Symmetry code: (i) x-1, y, z.

Data collection: APEX2 (Bruker, 2004[Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2004[Bruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); software used to prepare material for publication: SHELXTL and PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).

Supporting information


Comment top

1,2,4-Triazoles and their derivatives have long been known to exhibit diverse biological and pharmacological activities, such as antitubercular, anticancer (Vlasova et al., 1971; Kalluraya et al., 1996), anticonvulsant (Almasirad et al., 2004; Kanazawa et al., 1988; Chai et al., 2003; Hashimoto et al., 1990), anti-inflammatory (Labanauskas et al. ,2004), herbicidal, and analgesic properties (Tozkoparan et al., 2007; Amir & Shikha, 2004). Also, antifungal activity of aromatic ethers possessing a 1H-1,2,4-triazole ring has been reported (Wahbi et al., 1995). Herein, we report the synthesis and crystal structure of the title compound, (I).

In the molecule of the title compound (Fig. 1) the bond lengths and angles are generally within normal ranges. The planar 1,2,4-triazole ring is oriented at dihedral angles of 3.6 (2)° and 14.9 (6)° with respect to the 4-difluoromethoxy-substituted benzene ring and 2,3-dimethyl-substituted benzene ring, respectively. The CHF2 group is twisted away from the plane of the benzene ring, as shown by the C1—O1—C2—C3 torsion angle [145.8 (2)°].

Related literature top

For general background regarding the biological and pharmacological activities of 1,2,4-triazoles and their derivatives, see: Wahbi et al. (1995); Chai et al. (2003); Hashimoto et al. (1990); Kalluraya et al. (1996); Almasirad et al. (2004); Amir & Shikha (2004); Kanazawa et al. (1988); Vlasova et al. (1971); Labanauskas et al. (2004); Tozkoparan et al. (2007). For related syntheses, see: Drutkowski et al. (2002); Frohberg et al. (2002).

Experimental top

The general procedure to synthesize the title compound: 2-amine-N-(2,3-dimethyl-phenyl)-2-[(4-difluoromethoxy- phenyl)hydrazono]acetamide (10 mmol), 1.5 mL of a 37%-solution of formaldehyde (20 mmol) and 0.1 g p-toluene sulfonic acid were refluxed in approximately 50 mL ethanol. The reaction was complete after 10 h. The mixture was cooled to room temperature and the solvent was evaporated. The solid product was collected and recrystallized from 2-propanol (Drutkowski et al., 2002; Frohberg et al., 2002).

Refinement top

H atoms were placed in calculated positions with C—H = 0.95–0.99 Å, and refined in riding mode with Uiso(H) = 1.2Ueq(C).

Computing details top

Data collection: APEX2 (Bruker, 2004); cell refinement: SAINT (Bruker, 2004); data reduction: SAINT (Bruker, 2004); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Figures top
[Figure 1] Fig. 1. View of the title compound showing the atom numbering scheme and the ellipsoids at the 50% probability level.
1-[4-(Difluoromethoxy)phenyl]-N-(2,3-dimethylphenyl)-1H-1,2,4- triazole-3-carboxamide top
Crystal data top
C18H16F2N4O2V = 839.28 (19) Å3
Mr = 358.35Z = 2
Triclinic, P1F(000) = 372
a = 7.5543 (10) ÅDx = 1.418 Mg m3
b = 7.8132 (10) ÅMo Kα radiation, λ = 0.71073 Å
c = 14.8190 (19) ŵ = 0.11 mm1
α = 95.974 (2)°T = 296 K
β = 98.593 (1)°Block, white
γ = 101.523 (1)°0.49 × 0.31 × 0.10 mm
Data collection top
Bruker APEXII CCD
diffractometer
3115 independent reflections
Radiation source: fine-focus sealed tube2366 reflections with I > 2σ(I)
Graphite monochromatorRint = 0.017
ϕ and ω scansθmax = 25.5°, θmin = 2.7°
Absorption correction: multi-scan
(SADABS; Bruker, 2004)
h = 99
Tmin = 0.948, Tmax = 0.990k = 99
6446 measured reflectionsl = 1717
Refinement top
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.042H-atom parameters constrained
wR(F2) = 0.123 w = 1/[σ2(Fo2) + (0.0593P)2 + 0.1647P]
where P = (Fo2 + 2Fc2)/3
S = 1.06(Δ/σ)max < 0.001
3115 reflectionsΔρmax = 0.23 e Å3
238 parametersΔρmin = 0.21 e Å3
0 restraintsExtinction correction: SHELXL, Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.016 (3)
Crystal data top
C18H16F2N4O2γ = 101.523 (1)°
Mr = 358.35V = 839.28 (19) Å3
Triclinic, P1Z = 2
a = 7.5543 (10) ÅMo Kα radiation
b = 7.8132 (10) ŵ = 0.11 mm1
c = 14.8190 (19) ÅT = 296 K
α = 95.974 (2)°0.49 × 0.31 × 0.10 mm
β = 98.593 (1)°
Data collection top
Bruker APEXII CCD
diffractometer
3115 independent reflections
Absorption correction: multi-scan
(SADABS; Bruker, 2004)
2366 reflections with I > 2σ(I)
Tmin = 0.948, Tmax = 0.990Rint = 0.017
6446 measured reflections
Refinement top
R[F2 > 2σ(F2)] = 0.0420 restraints
wR(F2) = 0.123H-atom parameters constrained
S = 1.06Δρmax = 0.23 e Å3
3115 reflectionsΔρmin = 0.21 e Å3
238 parameters
Special details top

Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes.

Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2) top
xyzUiso*/Ueq
F10.9182 (2)0.3392 (2)0.14577 (12)0.1146 (6)
F20.8560 (2)0.1332 (2)0.05859 (11)0.1113 (6)
O10.6301 (2)0.3298 (2)0.13688 (9)0.0742 (4)
O20.41124 (16)0.80678 (19)0.54210 (9)0.0634 (4)
N10.15235 (18)0.67315 (18)0.45595 (9)0.0458 (4)
N20.03287 (19)0.69741 (19)0.46115 (10)0.0472 (4)
N30.0355 (2)0.8275 (2)0.59091 (11)0.0663 (5)
N40.32482 (19)0.9655 (2)0.66010 (10)0.0513 (4)
H4D0.22850.99010.67790.062*
C10.7981 (3)0.2345 (3)0.13967 (17)0.0766 (7)
H10.79440.16320.19030.092*
C20.5184 (3)0.4106 (2)0.21999 (13)0.0541 (5)
C30.3332 (3)0.4212 (3)0.22448 (13)0.0611 (5)
H30.28990.37080.17490.073*
C40.2118 (3)0.5063 (3)0.30237 (13)0.0556 (5)
H40.08660.51300.30570.067*
C50.2770 (2)0.5815 (2)0.37546 (11)0.0444 (4)
C60.4633 (2)0.5707 (2)0.37090 (13)0.0539 (5)
H60.50690.62120.42030.065*
C70.5839 (3)0.4846 (3)0.29260 (13)0.0577 (5)
H70.70930.47680.28910.069*
C80.1882 (3)0.7512 (3)0.53408 (14)0.0649 (6)
H80.30530.75130.54640.078*
C90.0950 (2)0.7909 (2)0.54299 (11)0.0460 (4)
C100.2942 (2)0.8537 (2)0.58047 (11)0.0448 (4)
C110.4936 (2)1.0475 (2)0.71818 (12)0.0464 (4)
C120.6569 (2)1.0709 (2)0.68418 (13)0.0538 (5)
H120.65751.03100.62290.065*
C130.8177 (3)1.1539 (3)0.74204 (14)0.0599 (5)
H130.92801.16820.72000.072*
C140.8166 (3)1.2157 (3)0.83215 (14)0.0629 (5)
H140.92661.27130.87040.076*
C150.6546 (3)1.1965 (3)0.86695 (13)0.0572 (5)
C160.4892 (2)1.1100 (2)0.80967 (12)0.0506 (4)
C170.6597 (3)1.2699 (3)0.96572 (15)0.0823 (7)
H17A0.78401.32310.99410.124*
H17B0.61181.17620.99840.124*
H17C0.58641.35700.96750.124*
C180.3094 (3)1.0884 (3)0.84471 (14)0.0703 (6)
H18A0.24201.17060.82080.105*
H18B0.33301.11050.91080.105*
H18C0.23890.97030.82480.105*
Atomic displacement parameters (Å2) top
U11U22U33U12U13U23
F10.0681 (9)0.1287 (13)0.1263 (13)0.0247 (9)0.0216 (9)0.0270 (10)
F20.1052 (12)0.1003 (11)0.0926 (11)0.0021 (9)0.0311 (9)0.0318 (8)
O10.0631 (9)0.0896 (11)0.0523 (8)0.0000 (8)0.0083 (7)0.0111 (7)
O20.0403 (7)0.0849 (10)0.0585 (8)0.0131 (7)0.0075 (6)0.0162 (7)
N10.0359 (8)0.0537 (8)0.0444 (8)0.0091 (6)0.0045 (6)0.0034 (6)
N20.0356 (8)0.0569 (9)0.0460 (8)0.0084 (6)0.0055 (6)0.0017 (7)
N30.0412 (9)0.0964 (13)0.0542 (10)0.0167 (8)0.0046 (7)0.0201 (9)
N40.0378 (8)0.0640 (10)0.0482 (9)0.0110 (7)0.0053 (6)0.0065 (7)
C10.0699 (15)0.0672 (14)0.0725 (15)0.0012 (12)0.0212 (11)0.0079 (11)
C20.0521 (11)0.0548 (11)0.0466 (10)0.0044 (8)0.0037 (8)0.0005 (8)
C30.0570 (12)0.0698 (13)0.0502 (11)0.0090 (10)0.0090 (9)0.0105 (9)
C40.0431 (10)0.0625 (11)0.0562 (11)0.0076 (8)0.0075 (8)0.0050 (9)
C50.0410 (9)0.0456 (9)0.0425 (9)0.0072 (7)0.0015 (7)0.0009 (7)
C60.0436 (10)0.0648 (12)0.0495 (11)0.0138 (9)0.0027 (8)0.0050 (9)
C70.0410 (10)0.0693 (12)0.0582 (12)0.0123 (9)0.0005 (8)0.0001 (9)
C80.0379 (10)0.0943 (15)0.0557 (11)0.0151 (10)0.0055 (8)0.0180 (10)
C90.0397 (9)0.0541 (10)0.0428 (9)0.0117 (8)0.0056 (7)0.0004 (8)
C100.0396 (9)0.0511 (10)0.0421 (9)0.0100 (7)0.0054 (7)0.0012 (7)
C110.0413 (9)0.0497 (10)0.0451 (10)0.0091 (7)0.0030 (7)0.0013 (8)
C120.0469 (10)0.0614 (11)0.0496 (10)0.0084 (8)0.0078 (8)0.0010 (8)
C130.0433 (10)0.0661 (12)0.0638 (12)0.0047 (9)0.0059 (9)0.0008 (10)
C140.0485 (11)0.0651 (12)0.0638 (13)0.0056 (9)0.0084 (9)0.0033 (10)
C150.0601 (12)0.0597 (11)0.0472 (10)0.0145 (9)0.0024 (9)0.0008 (9)
C160.0514 (10)0.0557 (11)0.0436 (10)0.0150 (8)0.0037 (8)0.0018 (8)
C170.0873 (17)0.0976 (18)0.0509 (12)0.0169 (14)0.0047 (11)0.0101 (11)
C180.0616 (13)0.0961 (16)0.0510 (12)0.0169 (11)0.0128 (10)0.0033 (11)
Geometric parameters (Å, º) top
F1—C11.345 (3)C6—C71.381 (2)
F2—C11.330 (3)C6—H60.9300
O1—C11.346 (3)C7—H70.9300
O1—C21.394 (2)C8—H80.9300
O2—C101.215 (2)C9—C101.487 (2)
N1—C81.341 (2)C11—C121.387 (2)
N1—N21.3632 (19)C11—C161.400 (2)
N1—C51.428 (2)C12—C131.374 (3)
N2—C91.316 (2)C12—H120.9300
N3—C81.314 (2)C13—C141.374 (3)
N3—C91.355 (2)C13—H130.9300
N4—C101.353 (2)C14—C151.385 (3)
N4—C111.417 (2)C14—H140.9300
N4—H4D0.8600C15—C161.402 (3)
C1—H10.9800C15—C171.507 (3)
C2—C71.372 (3)C16—C181.510 (3)
C2—C31.376 (3)C17—H17A0.9600
C3—C41.377 (3)C17—H17B0.9600
C3—H30.9300C17—H17C0.9600
C4—C51.380 (2)C18—H18A0.9600
C4—H40.9300C18—H18B0.9600
C5—C61.384 (2)C18—H18C0.9600
C1—O1—C2118.10 (17)N2—C9—N3115.33 (15)
C8—N1—N2109.18 (14)N2—C9—C10122.68 (15)
C8—N1—C5129.19 (15)N3—C9—C10121.99 (15)
N2—N1—C5121.60 (13)O2—C10—N4125.87 (16)
C9—N2—N1102.16 (13)O2—C10—C9122.19 (15)
C8—N3—C9102.47 (15)N4—C10—C9111.94 (14)
C10—N4—C11129.00 (15)C12—C11—C16121.23 (16)
C10—N4—H4D115.5C12—C11—N4120.80 (16)
C11—N4—H4D115.5C16—C11—N4117.93 (15)
F2—C1—F1105.50 (18)C13—C12—C11119.26 (17)
F2—C1—O1106.7 (2)C13—C12—H12120.4
F1—C1—O1110.9 (2)C11—C12—H12120.4
F2—C1—H1111.2C14—C13—C12120.48 (18)
F1—C1—H1111.2C14—C13—H13119.8
O1—C1—H1111.2C12—C13—H13119.8
C7—C2—C3120.57 (17)C13—C14—C15121.14 (18)
C7—C2—O1123.26 (18)C13—C14—H14119.4
C3—C2—O1116.09 (17)C15—C14—H14119.4
C2—C3—C4120.04 (18)C14—C15—C16119.45 (18)
C2—C3—H3120.0C14—C15—C17119.27 (19)
C4—C3—H3120.0C16—C15—C17121.28 (19)
C3—C4—C5119.59 (18)C11—C16—C15118.43 (17)
C3—C4—H4120.2C11—C16—C18120.51 (16)
C5—C4—H4120.2C15—C16—C18121.04 (17)
C4—C5—C6120.32 (16)C15—C17—H17A109.5
C4—C5—N1120.17 (15)C15—C17—H17B109.5
C6—C5—N1119.50 (15)H17A—C17—H17B109.5
C7—C6—C5119.65 (17)C15—C17—H17C109.5
C7—C6—H6120.2H17A—C17—H17C109.5
C5—C6—H6120.2H17B—C17—H17C109.5
C2—C7—C6119.82 (18)C16—C18—H18A109.5
C2—C7—H7120.1C16—C18—H18B109.5
C6—C7—H7120.1H18A—C18—H18B109.5
N3—C8—N1110.85 (16)C16—C18—H18C109.5
N3—C8—H8124.6H18A—C18—H18C109.5
N1—C8—H8124.6H18B—C18—H18C109.5
C8—N1—N2—C90.5 (2)C8—N3—C9—N20.1 (2)
C5—N1—N2—C9177.77 (15)C8—N3—C9—C10179.36 (18)
C2—O1—C1—F2162.99 (17)C11—N4—C10—O22.5 (3)
C2—O1—C1—F182.6 (2)C11—N4—C10—C9177.38 (16)
C1—O1—C2—C737.5 (3)N2—C9—C10—O28.1 (3)
C1—O1—C2—C3145.8 (2)N3—C9—C10—O2172.46 (18)
C7—C2—C3—C40.1 (3)N2—C9—C10—N4172.08 (16)
O1—C2—C3—C4176.96 (18)N3—C9—C10—N47.4 (2)
C2—C3—C4—C50.4 (3)C10—N4—C11—C1222.9 (3)
C3—C4—C5—C60.4 (3)C10—N4—C11—C16159.57 (17)
C3—C4—C5—N1178.75 (17)C16—C11—C12—C131.4 (3)
C8—N1—C5—C4178.5 (2)N4—C11—C12—C13178.84 (17)
N2—N1—C5—C43.6 (2)C11—C12—C13—C141.1 (3)
C8—N1—C5—C62.4 (3)C12—C13—C14—C150.1 (3)
N2—N1—C5—C6175.54 (16)C13—C14—C15—C161.1 (3)
C4—C5—C6—C70.2 (3)C13—C14—C15—C17178.7 (2)
N1—C5—C6—C7178.98 (16)C12—C11—C16—C150.4 (3)
C3—C2—C7—C60.1 (3)N4—C11—C16—C15177.95 (16)
O1—C2—C7—C6176.50 (17)C12—C11—C16—C18178.06 (18)
C5—C6—C7—C20.1 (3)N4—C11—C16—C180.5 (3)
C9—N3—C8—N10.2 (2)C14—C15—C16—C110.8 (3)
N2—N1—C8—N30.5 (2)C17—C15—C16—C11178.95 (19)
C5—N1—C8—N3177.64 (17)C14—C15—C16—C18179.26 (19)
N1—N2—C9—N30.4 (2)C17—C15—C16—C180.5 (3)
N1—N2—C9—C10179.09 (15)
Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N4—H4D···N30.862.272.717 (2)113
C6—H6···O2i0.932.433.344 (2)169
C8—H8···O2i0.932.263.159 (2)162
Symmetry code: (i) x1, y, z.

Experimental details

Crystal data
Chemical formulaC18H16F2N4O2
Mr358.35
Crystal system, space groupTriclinic, P1
Temperature (K)296
a, b, c (Å)7.5543 (10), 7.8132 (10), 14.8190 (19)
α, β, γ (°)95.974 (2), 98.593 (1), 101.523 (1)
V3)839.28 (19)
Z2
Radiation typeMo Kα
µ (mm1)0.11
Crystal size (mm)0.49 × 0.31 × 0.10
Data collection
DiffractometerBruker APEXII CCD
diffractometer
Absorption correctionMulti-scan
(SADABS; Bruker, 2004)
Tmin, Tmax0.948, 0.990
No. of measured, independent and
observed [I > 2σ(I)] reflections
6446, 3115, 2366
Rint0.017
(sin θ/λ)max1)0.606
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.042, 0.123, 1.06
No. of reflections3115
No. of parameters238
H-atom treatmentH-atom parameters constrained
Δρmax, Δρmin (e Å3)0.23, 0.21

Computer programs: APEX2 (Bruker, 2004), SAINT (Bruker, 2004), SHELXS97 (Sheldrick, 2008), SHELXL97 (Sheldrick, 2008), SHELXTL (Sheldrick, 2008) and PLATON (Spek, 2009).

Hydrogen-bond geometry (Å, º) top
D—H···AD—HH···AD···AD—H···A
N4—H4D···N30.862.272.717 (2)112.9
C6—H6···O2i0.932.433.344 (2)168.8
C8—H8···O2i0.932.263.159 (2)162.2
Symmetry code: (i) x1, y, z.
 

Acknowledgements

The authors are grateful for the financial support of the Education Office Foundation of Zhejiang Province (project No. Y200803795).

References

First citationAlmasirad, A., Tabatabai, S. A., Faizi, M., Kebriaeezadeh, A., Mehrabi, N., Dalvandi, A. & Shafiee, A. (2004). Bioorg. Med. Chem. Lett. 14, 6057–6059.  Web of Science CrossRef PubMed CAS Google Scholar
First citationAmir, M. & Shikha, K. (2004). Eur. J. Med. Chem. 39, 535–545.  Web of Science CrossRef PubMed CAS Google Scholar
First citationBruker (2004). APEX2 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.  Google Scholar
First citationChai, B., Qian, X., Cao, S., Liu, H. & Song, G. (2003). Arkivoc. ii, 141–145.  CrossRef Google Scholar
First citationDrutkowski, G., Donner, Ch., Schulze, I. & Frohberg, P. (2002). Tetrahedron, 58, 5317–5326.  Web of Science CrossRef CAS Google Scholar
First citationFrohberg, P., Drutkowski, G. & Wagner, Ch. (2002). Eur. J. Org. Chem. pp. 1654–1663.  CrossRef Google Scholar
First citationHashimoto, F., Sugimoto, C. & Hayashi, H. (1990). Chem. Pharm. Bull. 38, 2532–2536.  CrossRef CAS PubMed Web of Science Google Scholar
First citationKalluraya, B., Shetty, S. N., Gunaga, P. & Holla, B. S. (1996). Boll. Chim. Farm. 135, 638–642.  CAS PubMed Google Scholar
First citationKanazawa, S., Driscoll, M. & Struhl, K. (1988). Mol. Cell. Biol. 8, 644–673.  Google Scholar
First citationLabanauskas, L., Udrenaite, E., Gaidelis, P. & Brukštus, A. (2004). Farmaco, 59, 255–259.  CrossRef PubMed CAS Google Scholar
First citationSheldrick, G. M. (2008). Acta Cryst. A64, 112–122.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationSpek, A. L. (2009). Acta Cryst. D65, 148–155.  Web of Science CrossRef CAS IUCr Journals Google Scholar
First citationTozkoparan, B., Küpeli, E., Yeşilada, E. & Ertan, M. (2007). Bioorg. Med. Chem. 15, 1808–1814.  Web of Science CrossRef PubMed CAS Google Scholar
First citationVlasova, L. A., Shamaeva, E. M., Afanaséva, G. B. & Postvskii, I. Y. (1971). Pharm. Chem. J. 5, 473–477.  CrossRef Google Scholar
First citationWahbi, Y., Caujolle, R., Tournaire, C., Payard, M., Linas, M. D. & Seguela, J. P. (1995). Eur. J. Med. Chem. 30, 955–962.  CrossRef CAS Web of Science Google Scholar

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890
Volume 65| Part 5| May 2009| Pages o1015-o1016
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds